ZVRA
Zevra TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
ZVRA vs peer average
66/100
ZVRA vs. peer average (B vs. C)
Grade spread
A 1 · B 3 · C 2 · D 5
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
LXRX is the first available peer comparator.
Similar small-cap biopharma risk bucket and market-cap range from the packet, but still a loose operating peer; useful mainly for commercial-stage biotech valuation context rather than direct product comparability.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ZVRA
Zevra Therapeutics
LXRX
Lexicon
Grade
B
D
Momentum
71
50
Value
52
41
Sentiment
49
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs LXRX
ZVRA / LXRX
Grade Position
In line
ZVRA vs. peer average (B vs. C)
66/100
Momentum
71
ZVRAValue
52
ZVRASentiment
49
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ZVRA
LXRX is the first peer returned for this comparison set.